查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1571688

感染監測解決方案市場規模、佔有率、趨勢分析報告：按組件、最終用途、地區、細分市場預測，2024-2030 年

Infection Surveillance Solutions Market Size, Share & Trends Analysis Report By Component (Services, Software), By End-use (Long Term Care Facilities, Hospitals, Clinics), By Region, And Segment Forecasts, 2024 - 2030
出版日期: | 出版商: Grand View Research | 英文 100 Pages | 商品交期: 2-10個工作天內

價格
簡介目錄

感染監測解決方案市場成長與趨勢：

Grand View Research, Inc.最新報告顯示，預計2030年全球感染監測解決方案市場規模將達14.8億美元，2024年至2030年複合年成長率為13.1%。

全球醫療保健環境的改善和醫療保健IT基礎設施的進步預計將在市場的成長中發揮關鍵作用。醫療保健相關感染（HAI）盛行率的增加是推動市場的關鍵因素之一。

根據美國美國就發現了約 722,000 例醫院感染。此外，根據加州公共衛生部 (CDPH) 的數據，2016 年，400 家急診醫院報告了 18,924 例 HAI 病例。此外，根據歐盟委員會（EC）公佈的事實，歐盟（EU）約有25,000人死於抗生素抗藥性細菌。如果目前的感染趨勢持續到 2050 年，這一數字預計將增加到每年 1000 萬。

不斷增加的研究合作和政府舉措也刺激了市場成長。例如，2018 年 1 月，印度醫學研究委員會 (ICMR) 與輝瑞簽署了夥伴關係協議，以實施抗菌藥物抗藥性管理計畫。目標是擴大印度的抗菌素抗藥性監控網路。

感染監測解決方案市場報告亮點

  • 到2023年，軟體產業將佔據63.4%的主導市場佔有率。使用基於網路的軟體可以進行即時分析和各種設定。
  • 預計服務業將成為成長最快的行業，預測期內複合年成長率為 13.5%。
  • 到2023年，醫院細分市場將佔據79.3%的壓倒性市場佔有率。醫療保健機構購買力的提高、對追蹤軟體的需求增加以及熟練的醫療專業人員的可用性預計將有助於該行業的成長。
  • 長期照護機構預計將成為成長最快的領域，預測期內複合年成長率為 14.0%。
  • 2023年，北美感染監測解決方案市場將佔全球佔有率的50.3%。
  • 歐洲感染監測解決方案市場正在快速成長，2023年全球佔有率將達到22.2%。這一成長可歸因於醫療旅遊的增加、慢性病的增加和COVID-19的爆發等因素，這些因素對市場的成長產生了重大影響。

目錄

第1章調查方法和範圍

第 2 章執行摘要

第3章全球感染監測解決方案市場變數、趨勢和範圍

  • 市場介紹/系統展望
  • 市場規模及成長前景
  • 市場動態
    • 市場促進因素分析
    • 市場限制因素分析
  • 感染監測解決方案市場分析工具
    • 波特的分析
    • PESTEL分析

第 4 章 感染監測解決方案市場：成分估計與趨勢分析

  • 細分儀表板
  • 感染監控解決方案市場：2023 年和 2030 年組件變化分析
  • 服務
  • 軟體

第5章感染監測解決方案市場：最終用途估計與趨勢分析

  • 細分儀表板
  • 感染監控解決方案市場：2023 年和 2030 年最終用途變化分析
  • 醫院
  • 長期照護設施
  • 其他

第6章感染監測解決方案市場：區域估計和趨勢分析

  • 2023 年及 2030 年感染監測解決方案市場佔有率（按地區）
  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 西班牙
    • 義大利
    • 挪威
    • 丹麥
    • 瑞典
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 韓國
    • 澳洲
    • 泰國
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中東和非洲
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 科威特
    • 南非

第7章 競爭格局

  • 主要市場參與企業的最新趨勢和影響分析
  • 公司分類
  • 企業熱力圖分析
  • 公司簡介
    • Becton Dickinson and Company
    • Premier, Inc
    • Wolters Kluwer NV
    • Cerner Corporation（Oracle）
    • Clinisys
    • GOJO Industries, Inc
    • Baxter International Inc.
    • Vigilanz Corporation
    • Truven Health Analytics
    • RL Datix Ltd
簡介目錄
Product Code: GVR-2-68038-661-5

Infection Surveillance Solutions Market Growth & Trends:

The global infection surveillance solutions market size is expected to reach USD 1.48 billion by 2030, registering a CAGR of 13.1% from 2024 to 2030, according to a new report by Grand View Research, Inc. Improving healthcare settings worldwide coupled with advancements in healthcare IT infrastructure is projected to play a pivotal role in the growth of the market. Rising prevalence of healthcare-associated infections (HAIs) has been one of the critical factors driving the market.

According to HAI Prevalence Survey conducted by the Center for Disease Control and Prevention (CDC), in 2014, around 722,000 cases of HAIs were detected in the U.S hospitals alone. Moreover, according to the California Department of Public Health (CDPH) in 2016, 18,924 HAIs cases were reported in 400 acute care hospitals. In addition, as per facts published by the European Commission (EC), around 25,000 people die in the European Union (EU) from antibiotic-resistant bacteria. The figure is expected to increase to 10 million deaths per year if the current infection trend continues by 2050.

Rising collaboration and government initiatives are also stimulating the growth of the market. For instance, in January 2018, the Indian Council of Medical Research (ICMR) and Pfizer, Inc. signed a partnership agreement to introduce anti-microbial resistance stewardship programs. The objective was to scale up the AMR surveillance network in India.

Infection Surveillance Solutions Market Report Highlights:

  • The software segment dominated with a market share of 63.4% in 2023. The use of web-based software provides real-time analysis and different configurations.
  • The services segment is expected to be the fastest-growing segment with a CAGR of 13.5% during the forecast period.
  • The hospital segment dominated with a market share of 79.3% in 2023. High purchasing power by healthcare institutes, the growing need for tracking software, and the presence of skilled medical professionals are poised to contribute to the segment's growth.
  • Long-term care facilities are expected to be the fastest-growing segment with a CAGR of 14.0% during the forecast period.
  • North America infection surveillance solutions market accounted for a global share of 50.3% in 2023.
  • Europe's infection surveillance solutions market is fast-growing with a global share of 22.2% in 2023. The growth can be attributed to factors such as an increase in medical tourism, a rise in chronic diseases, and an outbreak of COVID-19 majorly played a role in influencing the market growth.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Market Definitions
  • 1.3. Research Methodology
    • 1.3.1. Information Procurement
    • 1.3.2. Information or Data Analysis
    • 1.3.3. Market Formulation & Data Visualization
    • 1.3.4. Data Validation & Publishing
  • 1.4. Research Scope and Assumptions
    • 1.4.1. List of Data Sources

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Competitive Insights

Chapter 3. Global Infection Surveillance Solutions Market Variables, Trends, & Scope

  • 3.1. Market Introduction/Lineage Outlook
  • 3.2. Market Size and Growth Prospects (USD Million)
  • 3.3. Market Dynamics
    • 3.3.1. Market Drivers Analysis
    • 3.3.2. Market Restraints Analysis
  • 3.4. Infection Surveillance Solutions Market Analysis Tools
    • 3.4.1. Porter's Analysis
      • 3.4.1.1. Bargaining power of the suppliers
      • 3.4.1.2. Bargaining power of the buyers
      • 3.4.1.3. Threats of substitution
      • 3.4.1.4. Threats from new entrants
      • 3.4.1.5. Competitive rivalry
    • 3.4.2. PESTEL Analysis
      • 3.4.2.1. Political landscape
      • 3.4.2.2. Economic and Social landscape
      • 3.4.2.3. Technological landscape
      • 3.4.2.4. Environmental landscape
      • 3.4.2.5. Legal landscape

Chapter 4. Infection Surveillance Solutions Market: Component Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. Infection Surveillance Solutions Market: Component Movement Analysis, 2023 & 2030 (USD Million)
  • 4.3. Services
    • 4.3.1. Maintenance and Support Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.3.2. Consultation and Training Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.3.3. Implementation Service Market Revenue Estimated and Forecasts, 2018 - 2030 (USD Million)
  • 4.4. Software Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.4.1. On Premise Market Revenue Estimated and Forecasts, 2018 - 2030 (USD Million)
    • 4.4.2. Web Based Market Revenue Estimated and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. Infection Surveillance Solutions Market: End Use Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. Infection Surveillance Solutions Market: End Use Movement Analysis, 2023 & 2030 (USD Million)
  • 5.3. Hospitals
    • 5.3.1. Hospitals Market Revenue Estimates and Forecasts, 2018 - 2030(USD Million)
  • 5.4. Long Term Care Facilities
    • 5.4.1. Long Term Care Facilities Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.5. Others
    • 5.5.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 6. Infection Surveillance Solutions Market: Regional Estimates & Trend Analysis

  • 6.1. Infection Surveillance Solutions Market Share, By Region, 2023 & 2030 (USD Million)
  • 6.2. North America
    • 6.2.1. North America Infection Surveillance Solutions Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.2.2. U.S.
      • 6.2.2.1. U.S. Infection Surveillance Solutions Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.2.3. Canada
      • 6.2.3.1. Canada Infection Surveillance Solutions Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.2.4. Mexico
      • 6.2.4.1. Mexico Infection Surveillance Solutions Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.3. Europe
    • 6.3.1. Europe Infection Surveillance Solutions Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.3.2. UK
      • 6.3.2.1. UK Infection Surveillance Solutions Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.3.3. Germany
      • 6.3.3.1. Germany Infection Surveillance Solutions Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.3.4. France
      • 6.3.4.1. France Infection Surveillance Solutions Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.3.5. Spain
      • 6.3.5.1. Spain Infection Surveillance Solutions Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.3.6. Italy
      • 6.3.6.1. Italy Infection Surveillance Solutions Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.3.7. Norway
      • 6.3.7.1. Norway Infection Surveillance Solutions Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.3.8. Denmark
      • 6.3.8.1. Denmark Infection Surveillance Solutions Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.3.9. Sweden
      • 6.3.9.1. Sweden Infection Surveillance Solutions Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.4. Asia Pacific
    • 6.4.1. Asia Pacific Infection Surveillance Solutions Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.4.2. China
      • 6.4.2.1. China Infection Surveillance Solutions Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.4.3. Japan
      • 6.4.3.1. Japan Infection Surveillance Solutions Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.4.4. India
      • 6.4.4.1. India Infection Surveillance Solutions Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.4.5. South Korea
      • 6.4.5.1. South Korea Infection Surveillance Solutions Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.4.6. Australia
      • 6.4.6.1. Australia Infection Surveillance Solutions Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.4.7. Thailand
      • 6.4.7.1. Thailand Infection Surveillance Solutions Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.5. Latin America
    • 6.5.1. Latin America Infection Surveillance Solutions Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.5.2. Brazil
      • 6.5.2.1. Brazil Infection Surveillance Solutions Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.5.3. Argentina
      • 6.5.3.1. Argentina Infection Surveillance Solutions Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.6. Middle East and Africa
    • 6.6.1. Middle East and Africa Infection Surveillance Solutions Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.6.2. Saudi Arabia
      • 6.6.2.1. Saudi Arabia Infection Surveillance Solutions Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.6.3. UAE
      • 6.6.3.1. UAE Infection Surveillance Solutions Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.6.4. Kuwait
      • 6.6.4.1. Kuwait Infection Surveillance Solutions Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.6.5. South Africa
      • 6.6.5.1. South Africa Infection Surveillance Solutions Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 7. Competitive Landscape

  • 7.1. Recent Developments & Impact Analysis by Key Market Participants
  • 7.2. Company Categorization
  • 7.3. Company Heat Map Analysis
  • 7.4. Company Profiles
    • 7.4.1. Becton Dickinson and Company
      • 7.4.1.1. Participant's Overview
      • 7.4.1.2. Financial Performance
      • 7.4.1.3. Product Benchmarking
      • 7.4.1.4. Recent Developments/ Strategic Initiatives
    • 7.4.2. Premier, Inc
      • 7.4.2.1. Participant's Overview
      • 7.4.2.2. Financial Performance
      • 7.4.2.3. Product Benchmarking
      • 7.4.2.4. Recent Developments/ Strategic Initiatives
    • 7.4.3. Wolters Kluwer N.V.
      • 7.4.3.1. Participant's Overview
      • 7.4.3.2. Financial Performance
      • 7.4.3.3. Product Benchmarking
      • 7.4.3.4. Recent Developments/ Strategic Initiatives
    • 7.4.4. Cerner Corporation (Oracle)
      • 7.4.4.1. Participant's Overview
      • 7.4.4.2. Financial Performance
      • 7.4.4.3. Product Benchmarking
      • 7.4.4.4. Recent Developments/ Strategic Initiatives
    • 7.4.5. Clinisys
      • 7.4.5.1. Participant's Overview
      • 7.4.5.2. Financial Performance
      • 7.4.5.3. Product Benchmarking
      • 7.4.5.4. Recent Developments/ Strategic Initiatives
    • 7.4.6. GOJO Industries, Inc
      • 7.4.6.1. Participant's Overview
      • 7.4.6.2. Financial Performance
      • 7.4.6.3. Product Benchmarking
      • 7.4.6.4. Recent Developments/ Strategic Initiatives
    • 7.4.7. Baxter International Inc.
      • 7.4.7.1. Participant's Overview
      • 7.4.7.2. Financial Performance
      • 7.4.7.3. Product Benchmarking
      • 7.4.7.4. Recent Developments/ Strategic Initiatives
    • 7.4.8. Vigilanz Corporation
      • 7.4.8.1. Participant's Overview
      • 7.4.8.2. Financial Performance
      • 7.4.8.3. Product Benchmarking
      • 7.4.8.4. Recent Developments/ Strategic Initiatives
    • 7.4.9. Truven Health Analytics
      • 7.4.9.1. Participant's Overview
      • 7.4.9.2. Financial Performance
      • 7.4.9.3. Product Benchmarking
      • 7.4.9.4. Recent Developments/ Strategic Initiatives
    • 7.4.10. RL Datix Ltd
      • 7.4.10.1. Participant's Overview
      • 7.4.10.2. Financial Performance
      • 7.4.10.3. Product Benchmarking
      • 7.4.10.4. Recent Developments/ Strategic Initiatives